XPHYF News and Press, XPhyto Therapeutics Corp From 07/27/21

There is huge debate on what medicinal properties, if any, marijuana possesses, and researchers are working to uncover the effects of this substance. For example, a team of researchers from the University of Copenhagen in Denmark has discovered that medical marijuana has the ability to reduc...

Research has found that medical marijuana possesses therapeutic benefits , and with more states across the country legalizing the use of medical marijuana in alleviating and managing symptoms of various indications, it is important to acquaint yourself with what this means for you, especial...

Researchers theorize that psychedelic substances differ from other recreational drugs because they do not lead to compulsive use or addiction and neither do they harm an individual’s brain. An analysis conducted by researchers from the Department of Neuroscience at the Norwegian Un...

A group of researchers from the United States and Israel conducted a study that compared the disease progression and presentation between in-hospital patients suffering from COVID-19 with other respiratory ailments such as influenza . They discovered that coronavirus patients displayed a ...

Moral injury is the social, behavioral, psychological and spiritual distress that occurs in response to witnessing a behavior or acting in a way that doesn’t align with an individual’s moral beliefs and values. Researchers assert that moral injuries are not psychiatric diagno...

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) , a bioscience technology accelerator, has signed a definitive agreement to acquire its exclusive diagnostics development partner 3a-diagnostics GmbH, Frickenhausen, Germany. Per the terms of the definitive agreement, XPhyto will acq...

The acquisition creates significant commercial development and manufacturing opportunities for XPhyto as well as cost synergies and improved margins on its diagnostic products. The acquisition secures XPhyto an experienced research and development team with a pipeline of ready-to-launc...

Since research on psychedelics was revived in the 2000s, prompted by the easing of the regulations that govern the substances, a lot of studies have shown that drugs such as LSD and psilocybin possess great therapeutic potential and can be used to treat conditions such as depression, anxiety...

XPhyto partners with AGORA t to grow its brand and overall market share The agreement entails shares issued to AGORA on August 21, 2021 and December 31, 2021 at a price of $2.12 per share, subject to a hold period that ends on October 18, 2021 AGORA is known for its online marketing, ...

A recent study conducted by researchers from the Academy of Finland has found that almost half of all coronavirus patients who also suffer from obstructive sleep apnea need to be hospitalized. The study , which was reported in the BMJ journals, noted that moderate to acute sleep apnea pre...